Jonathan A. Leff

2009

In 2009, Jonathan A. Leff earned a total compensation of $1.1M as Vice President and Chief Medical Officer at Halozyme Therapeutics.

Compensation breakdown

Bonus$25,000
Non-Equity Incentive Plan$4,014
Option Awards$877,780
Salary$177,500
Other$4,963
Total$1,089,257

Leff received $877.8K in option awards, accounting for 81% of the total pay in 2009.

Leff also received $25K in bonus, $4K in non-equity incentive plan, $177.5K in salary and $5K in other compensation.

Rankings

In 2009, Jonathan A. Leff's compensation ranked 4,171st out of 9,885 executives tracked by ExecPay. In other words, Leff earned more than 57.8% of executives.

ClassificationRankingPercentile
All
4,171
out of 9,885
58th
Division
Manufacturing
1,481
out of 3,690
60th
Major group
Chemicals And Allied Products
282
out of 871
68th
Industry group
Drugs
169
out of 643
74th
Industry
Biological Products, Except Diagnostic Substances
29
out of 138
79th
Source: SEC filing on March 24, 2011.

Leff's colleagues

We found eight more compensation records of executives who worked with Jonathan A. Leff at Halozyme Therapeutics in 2009.

2009

Kurt Gustafson

Halozyme Therapeutics

Chief Financial Officer

2009

Jonathan Lim

Halozyme Therapeutics

Chief Executive Officer

2009

H Shepard

Halozyme Therapeutics

Chief Scientific Officer

2009

Gregory Frost

Halozyme Therapeutics

Chief Executive Officer

2009

William Fallon

Halozyme Therapeutics

Vice President, Manufacturing & Operations

2009

David Ramsay

Halozyme Therapeutics

Vice President Corporate Development

2009

Robert Little

Halozyme Therapeutics

Vice President and Chief Commercial Officer

2009

Michael LaBarre

Halozyme Therapeutics

Vice President, Product Development

In-depth

You may also like